Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Allient Inc. stock logo
ALNT
Allient
$76.73
+2.9%
$66.97
$30.00
$80.39
$1.31B1.65184,312 shs120,993 shs
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
$13.97
+3.5%
$13.43
$6.85
$19.11
$1.17B1.761.17 million shs324,457 shs
Prenetics Global Limited stock logo
PRE
Prenetics Global
$20.98
+4.0%
$18.25
$5.58
$23.63
$353.85M0.15240,534 shs294,146 shs
Transcat, Inc. stock logo
TRNS
Transcat
$84.47
+7.0%
$75.99
$50.23
$91.45
$788.20M0.68145,267 shs198,568 shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Allient Inc. stock logo
ALNT
Allient
-1.17%+18.70%+0.35%+13.29%+138.38%
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
+2.58%+5.63%+0.22%-23.12%+91.76%
Prenetics Global Limited stock logo
PRE
Prenetics Global
+16.92%+26.76%+9.79%+19.34%+100.80%
Transcat, Inc. stock logo
TRNS
Transcat
-1.69%+11.53%+4.33%+1.27%-11.62%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Allient Inc. stock logo
ALNT
Allient
$76.73
+2.9%
$66.97
$30.00
$80.39
$1.31B1.65184,312 shs120,993 shs
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
$13.97
+3.5%
$13.43
$6.85
$19.11
$1.17B1.761.17 million shs324,457 shs
Prenetics Global Limited stock logo
PRE
Prenetics Global
$20.98
+4.0%
$18.25
$5.58
$23.63
$353.85M0.15240,534 shs294,146 shs
Transcat, Inc. stock logo
TRNS
Transcat
$84.47
+7.0%
$75.99
$50.23
$91.45
$788.20M0.68145,267 shs198,568 shs
The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Allient Inc. stock logo
ALNT
Allient
-1.17%+18.70%+0.35%+13.29%+138.38%
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
+2.58%+5.63%+0.22%-23.12%+91.76%
Prenetics Global Limited stock logo
PRE
Prenetics Global
+16.92%+26.76%+9.79%+19.34%+100.80%
Transcat, Inc. stock logo
TRNS
Transcat
-1.69%+11.53%+4.33%+1.27%-11.62%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Allient Inc. stock logo
ALNT
Allient
2.67
Moderate Buy$77.330.79% Upside
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
3.00
Buy$31.80127.65% Upside
Prenetics Global Limited stock logo
PRE
Prenetics Global
2.50
Moderate Buy$32.3354.12% Upside
Transcat, Inc. stock logo
TRNS
Transcat
2.60
Moderate Buy$105.3324.70% Upside

Current Analyst Ratings Breakdown

Latest PRE, EYPT, ALNT, and TRNS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/26/2026
Allient Inc. stock logo
ALNT
Allient
Set Price Target$80.00
5/26/2026
Allient Inc. stock logo
ALNT
Allient
Set Price Target$80.00
5/26/2026
Allient Inc. stock logo
ALNT
Allient
UpgradeNeutralOverweight$65.00 ➝ $80.00
5/15/2026
Transcat, Inc. stock logo
TRNS
Transcat
UpgradeStrong SellHold
5/11/2026
Allient Inc. stock logo
ALNT
Allient
DowngradeHold (C+)Hold (C)
5/8/2026
Allient Inc. stock logo
ALNT
Allient
Reiterated RatingBuy$70.00
5/8/2026
Allient Inc. stock logo
ALNT
Allient
Lower Price TargetNeutral$70.00 ➝ $65.00
5/7/2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
Lower Price TargetOutperform$39.00 ➝ $37.00
5/4/2026
Transcat, Inc. stock logo
TRNS
Transcat
Reiterated RatingSell (D)
4/21/2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
Reiterated RatingSell (D-)
4/21/2026
Prenetics Global Limited stock logo
PRE
Prenetics Global
Reiterated RatingSell (D-)
(Data available from 5/29/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Allient Inc. stock logo
ALNT
Allient
$554.48M2.35$3.74 per share20.52$18.00 per share4.26
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
$31.37M37.33N/AN/A$2.75 per share5.08
Prenetics Global Limited stock logo
PRE
Prenetics Global
$92.39M3.83N/AN/A$9.27 per share2.26
Transcat, Inc. stock logo
TRNS
Transcat
$331.88M2.37$4.49 per share18.82$30.82 per share2.74
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Allient Inc. stock logo
ALNT
Allient
$22.03M$1.4353.8926.10N/A4.25%12.47%6.37%8/5/2026 (Estimated)
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
-$231.96M-$3.50N/AN/AN/A-3,566.63%-110.54%-90.15%8/5/2026 (Estimated)
Prenetics Global Limited stock logo
PRE
Prenetics Global
-$37.71M-$4.02N/AN/AN/A-61.33%-19.61%-15.33%N/A
Transcat, Inc. stock logo
TRNS
Transcat
$14.52M$0.85145.6639.29N/A1.62%5.87%3.84%8/3/2026 (Estimated)

Latest PRE, EYPT, ALNT, and TRNS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/26/2026Q4 2026
Transcat, Inc. stock logo
TRNS
Transcat
$0.51$0.56+$0.05$0.21$89.79 million$89.33 million
5/6/2026Q1 2026
Allient Inc. stock logo
ALNT
Allient
$0.55$0.50-$0.05$0.32$138.42 million$138.92 million
5/6/2026Q1 2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
-$0.79-$0.99-$0.20-$0.99$0.35 million$0.70 million
3/5/2026Q4 2025
Allient Inc. stock logo
ALNT
Allient
$0.46$0.55+$0.09$0.38$133.33 million$143.35 million
3/4/2026Q4 2025
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
-$0.78-$0.8143-$0.0343-$0.81$1.01 million$0.62 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Allient Inc. stock logo
ALNT
Allient
$0.160.21%+8.45%11.19%N/A
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
N/AN/AN/AN/AN/A
Prenetics Global Limited stock logo
PRE
Prenetics Global
N/AN/AN/AN/AN/A
Transcat, Inc. stock logo
TRNS
Transcat
N/AN/AN/AN/AN/A

Latest PRE, EYPT, ALNT, and TRNS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/6/2026
Allient Inc. stock logo
ALNT
Allient
quarterly$0.040.25%5/21/20265/21/20266/4/2026
3/5/2026
Allient Inc. stock logo
ALNT
Allient
quarterly$0.030.2%3/20/20263/20/20264/3/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Allient Inc. stock logo
ALNT
Allient
0.58
3.73
2.15
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
N/A
6.66
6.63
Prenetics Global Limited stock logo
PRE
Prenetics Global
N/A
2.97
2.72
Transcat, Inc. stock logo
TRNS
Transcat
0.34
2.21
1.85

Institutional Ownership

CompanyInstitutional Ownership
Allient Inc. stock logo
ALNT
Allient
61.57%
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
99.41%
Prenetics Global Limited stock logo
PRE
Prenetics Global
25.01%
Transcat, Inc. stock logo
TRNS
Transcat
98.34%

Insider Ownership

CompanyInsider Ownership
Allient Inc. stock logo
ALNT
Allient
15.00%
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
4.46%
Prenetics Global Limited stock logo
PRE
Prenetics Global
7.80%
Transcat, Inc. stock logo
TRNS
Transcat
2.80%
CompanyEmployeesShares OutstandingFree FloatOptionable
Allient Inc. stock logo
ALNT
Allient
2,47817.00 million14.45 millionOptionable
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
12083.84 million80.10 millionOptionable
Prenetics Global Limited stock logo
PRE
Prenetics Global
116.87 million15.56 millionNot Optionable
Transcat, Inc. stock logo
TRNS
Transcat
1,2459.33 million9.07 millionOptionable

Recent News About These Companies

Transcat, Inc. (NASDAQ:TRNS) Q4 2026 Earnings Call Transcript
Transcat, Inc. (TRNS) Q4 2026 Earnings Call Transcript
Transcat Q4 Earnings Call Highlights
Transcat (TRNS) Projected to Post Earnings on Monday
Transcat Names Jaime Irick as CEO
Transcat, Inc. (TRNS) Q3 2026 Earnings Call Transcript

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Allient stock logo

Allient NASDAQ:ALNT

$76.72 +2.14 (+2.86%)
As of 02:15 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Allient Inc., together with its subsidiaries, designs, manufactures, and sells precision and specialty controlled motion components and systems for various industries in the United States, Canada, South America, Europe, and Asia-Pacific. It offers brush and brushless DC motors, brushless servo and torque motors, coreless DC motors, integrated brushless motor-drives, gearmotors, gearing, modular digital servo drives, motion controllers, optical encoders, active and passive filters, input/output modules, industrial communications gateways, light-weighting technologies, and other controlled motion-related products, as well as nano precision positioning systems, servo control systems, and digital servo amplifiers and drives. The company sells its products to end customers and original equipment manufacturers in vehicle, medical, aerospace and defense, and industrial markets through direct sales force, authorized manufacturers' representatives, and distributors. The company was formerly known as Allied Motion Technologies Inc. and changed its name to Allient Inc. in August 2023. Allient Inc. was incorporated in 1962 and is headquartered in Amherst, New York.

Eyepoint Pharmaceuticals stock logo

Eyepoint Pharmaceuticals NASDAQ:EYPT

$13.97 +0.47 (+3.47%)
As of 02:14 PM Eastern
This is a fair market value price provided by Massive. Learn more.

EyePoint Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible Durasert E technology for sustained intraocular drug delivery. Its lead product candidate is EYP-1901, an investigational sustained delivery treatment for VEGF-mediated retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor with Durasert E which is in Phase 2 clinical trials for wet age-related macular degeneration (wet AMD), non-proliferative diabetic retinopathy (NPDR), and diabetic macular edema (DME). The company's pipeline programs also include EYP-2301, a promising TIE-2 agonist formulated in Durasert E to potentially improve outcomes in serious retinal diseases. The company was formerly known as pSivida Corp. and changed its name to EyePoint Pharmaceuticals, Inc. in March 2018. EyePoint Pharmaceuticals, Inc. was incorporated in 1987 and is headquartered in Watertown, Massachusetts.

Prenetics Global stock logo

Prenetics Global NASDAQ:PRE

$20.98 +0.80 (+3.96%)
As of 02:14 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Prenetics Global Limited, a genomics-driven health sciences company, engages in revolutionizing prevention, early detection, and treatment. It offers CircleDNA, a prevention arm that uses whole exome sequencing to offer comprehensive consumer DNA test. The company also, through its joint venture, Insighta, engages in pioneering multi-cancer early detection technologies. In addition, the company, through its equity interests in ACT Genomics Holdings Company Limited, is involved in genomic profiling of solid tumors through ACTOnco. Prenetics Global Limited was founded in 2007 and is based in Quarry Bay, Hong Kong.

Transcat stock logo

Transcat NASDAQ:TRNS

$84.47 +5.51 (+6.98%)
As of 02:15 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Transcat, Inc. provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services. This segment also provides CalTrak, a proprietary document and asset management system that is used to manage the workflow of its calibration service centers and customers' assets; and Compliance, Control and Cost, an online customer portal that provides its customers with web-based asset management capability, as well as a safe and secure off-site archive of calibration and other service records. The Distribution segment sells and rents test, measurement, and control instruments for customers' test and measurement instrumentation needs, as well as value added services, such as calibration/certification of equipment purchase, equipment rental, used equipment for sale, and equipment kitting. This segment markets and sells its products through website, digital and print advertising, proactive outbound sales, and an inbound call center. The company provides services and products to highly regulated industries, principally life science, which includes companies in the pharmaceutical, biotechnology, medical device, and other FDA-regulated industries; and additional industries, including aerospace and defense industrial manufacturing, energy and utilities, and other industries that require accuracy in processes and confirmation of the capabilities of their equipment. Transcat, Inc. was incorporated in 1964 and is headquartered in Rochester, New York.